NewGenIvf Group Ltd
corporate_fare Company Profile
NewGenIvf Group Ltd (NASDAQ:NIVF) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 35 items for NIVF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-10, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 19 rated 8 or above. Recent SEC coverage for NIVF spans F-1/A, 4, F-1, 6-K.
Recent high-impact activity:
- NewGenIvf Registers $6M Best-Efforts Offering Plus 4.36M Resale Shares
- Director Cheung Kong Yiu Buys $4.16M of NIVF Shares — Nearly Half the Company's Market Cap
- NewGenIvf Files F-1 Amendment for $10M Best-Efforts Offering and 3.56M Share Resale
- NewGenIvf Files for $10M Best-Efforts Offering Amid Going Concern and Reverse Split
- NewGenIvf Sets 1-for-3 Reverse Split for September 1
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for NIVF, detected from its recent SEC filings · based on capital-structure filings through 2026-09-10.
$6M Best-Efforts Offering at $1.10 · Massive Dilution to Existing Holders
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
NIVF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.